ID   ZJB-ENC1
AC   CVCL_XI65
DR   CCRID; 4201PAT-CCTCC00919
DR   Wikidata; Q98136522
RX   Patent=CN106244554B;
RX   PubMed=31772679;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2016118.
CC   Population: Chinese.
CC   Doubling time: ~43 hours (PubMed=31772679).
CC   Omics: Deep exome analysis.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): Patent=CN106244554B; PubMed=31772679
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D12S391: 18,19
ST   D13S317: 10
ST   D16S539: 9,12
ST   D18S51: 12,17
ST   D19S433: 13
ST   D21S11: 30
ST   D2S1338: 20,21
ST   D3S1358: 15
ST   D5S818: 9,10
ST   D6S1043: 14,17
ST   D7S820: 11,12
ST   D8S1179: 10
ST   FGA: 22,26
ST   Penta D: 9,13
ST   Penta E: 14,27
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 17,20
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 9
//
RX   Patent=CN106244554B;
RA   Liu X.-Z., Zheng Z.-G., Ling Z.-Q., Ge M.-H., Sun W.-Y., Xu H.-M.,
RA   Sun W., Dai Y.-L., Han J., Gong W.-G., Yan X.-D., Wei H.-B.;
RT   "Human endometrial cancer cell line and application thereof.";
RL   Patent number CN106244554B, 25-Jun-2019.
//
RX   PubMed=31772679; DOI=10.7150/jca.33013;
RA   Liu X.-Z., Ren Z.-Z., Yu X., Sun W., Li Y.-F., Rui X.-M., Xie D.-F.,
RA   Meng X.-L., Zheng Z.-G.;
RT   "Establishment and characterization of novel human primary endometrial
RT   cancer cell line (ZJB-ENC1) and its genomic characteristic.";
RL   J. Cancer 10:6466-6474(2019).
//